Microbial Keratitis in Cairo University Hospitals
Incidence, Risk Factors and Microbiological Features of Infective Keratitis in Cairo University Hospitals
1 other identifier
observational
85
1 country
1
Brief Summary
The aim of the study was to identify the incidence of infective keratitis presenting to the ophthalmology emergency department at Cairo University hospital, the risk factors and the bacterial/fungal spectrum causing the ulcers and to determine the best possible empirical therapy followed by specific therapy after obtaining culture results.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2021
CompletedFirst Submitted
Initial submission to the registry
May 17, 2022
CompletedFirst Posted
Study publicly available on registry
May 24, 2022
CompletedMay 24, 2022
May 1, 2022
9 months
May 17, 2022
May 20, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
To identify risk factors and the most common causative organisms of microbial keratitis among the Egyptian population through history taking from each patient and the results of corneal sampling taken from the ulcer.
Thorough history taking including risk factors that contributed to the ulcer occurrence. Corneal sampling through corneal scraping from the base and edge of the ulcer that undergoes direct examination and culturing using standard laboratory protocols.
Three weeks for each participant
To detect incidence of infective keratitis amongst all ophthalmological casualty cases by documenting the number of cases presenting or referred to the casualty of the ophthalmology department.
Noting down the number of patients diagnosed with microbial keratitis that present to the casualty of a tertiary referral hospital, and calculate the percentage amongst all other ophthalmic casualty cases that present to the emergency as well.
through study completion, an average of eight months
To detect antimicrobial susceptibility and resistance of different antimicrobial agents causing corneal infections in our study group.
Antibiotic susceptibility testing was performed by the disc diffusion method (Modified Kirby Bauer technique) using Muller Hinton agar, aerobic incubation at 35°C for 16-18 hours. Anti fungal susceptibility was done using microdilution testing following the CLSI reference method.
two weeks for each participant
Secondary Outcomes (2)
To assess the impact of culture and sensitivity results of corneal scrapings on the initial empirical therapy by calculating the number of cases that needed to shift the initial therapy to another one according to the antimicrobial susceptibility.
six months
Improving lines of management of microbial keratitis for a better outcome based on the cooperation between clinical ophthalmologists and microbiologists to reach a proper diagnosis and tailor the management accordingly.
six months
Eligibility Criteria
Recruitment occurred from the Ophthalmology outpatient clinics and casualty department in Cairo University Hospitals, Kasr Al Aini. They met all inclusion and exclusion criteria for enrollment into this study.
You may qualify if:
- Patients presenting at the casualty who are clinically diagnosed as infectious keratitis , of all age groups and including both genders.
You may not qualify if:
- Patients presenting with clinical picture suggestive of
- Viral keratitis solely without superimposed secondary infection.
- Non infectious keratitis as peripheral ulcerative keratitis ( e.g. Mooren's ulcer, marginal keratitis, autoimmune keratitis )
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kasr Al Aini Hospital
Cairo, 11562, Egypt
Biospecimen
Corneal scrapings from cornea of infected eyes.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Yehia Mostafa, MD
Kasr Al Aini Hospital
- STUDY DIRECTOR
Mohamed El Agha, MD
Kasr Al Aini Hospital
- STUDY DIRECTOR
Ihab Othman, MD
Kasr Al Aini Hospital
- STUDY DIRECTOR
Moushira Hosny, MD
Kasr Al Aini Hospital
- PRINCIPAL INVESTIGATOR
Nevien Lotfy, MSc
Kasr Al Aini Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 2 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ophthalmology Resident at the Ophthalmology Department, Cairo University.
Study Record Dates
First Submitted
May 17, 2022
First Posted
May 24, 2022
Study Start
September 10, 2020
Primary Completion
May 30, 2021
Study Completion
June 15, 2021
Last Updated
May 24, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- After being published.
all IPD that underlie results in a publication.